Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2008

01-01-2008 | Research Article

Evaluation of pharmacist clinical interventions in a Dutch hospital setting

Authors: Liesbeth Bosma, Frank G. A. Jansman, Anton M. Franken, Johannes W. Harting, Patricia M. L. A. Van den Bemt

Published in: International Journal of Clinical Pharmacy | Issue 1/2008

Login to get access

Abstract

Objective

Assessing the relevance of a clinically active pharmacist method compared to the traditional working method.

Method

The study was carried out in a general internal/gastro-enterology unit during two 8-weeks periods in 2004. It was an observational, non-randomized prospective study. Outcome measures were compared before and during the intervention. The intervention was the active presence of a junior hospital pharmacist on the unit. The pharmacist focused on the pharmacotherapy of the individual patient. Patients were included when they used 5 or more medicines on day 1 or 2 of their stay at the ward and/or used at least 1 high-risk drug. Clinical pharmacist interventions were counted and classified. A hospital pharmacist and an internal medicine specialist assessed the clinical relevance of all clinical pharmacist interventions retrospectively. The degree of acceptance of the interventions by physicians was measured. Finally, time associated with the clinical activities was measured.

Main outcome measures

Number of interventions (related to number of medication orders), clinical relevance and degree of acceptance.

Results

In the pre-intervention period 79 patients were included versus 84 in the during-intervention period. About 82 interventions in the pre-intervention period were made compared to 173 during the during-intervention period. There was little agreement between the professional raters (weighted κA–E = 0.30 and weighted κ1–5 = 0.20). Nevertheless both ratings showed a substantial increase of clinically relevant interventions. The number of interventions accepted by the physician increased from 16 in the pre-intervention period to 75 in the during-intervention period. Working with this method took over 4 h a day.

Conclusion

Clinical pharmacy services provided by a junior hospital pharmacist on an internal medicine ward contribute to rationalization of drug therapy and are therefore likely to increase medication safety.
Literature
1.
go back to reference Van den Bemt PMLA, Egberts TCG, de Jong-van den Berg LTW, Brouwers JRBJ. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321–33.PubMedCrossRef Van den Bemt PMLA, Egberts TCG, de Jong-van den Berg LTW, Brouwers JRBJ. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321–33.PubMedCrossRef
2.
go back to reference Lustig A. Medication error prevention by pharmacists- An Israeli solution. Pharm World Sci 2000;22(1):21–5.PubMedCrossRef Lustig A. Medication error prevention by pharmacists- An Israeli solution. Pharm World Sci 2000;22(1):21–5.PubMedCrossRef
3.
go back to reference Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014–7.PubMedCrossRef Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014–7.PubMedCrossRef
4.
go back to reference Scarsi KK, Fotis MA, Noskon GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002;59:2089–92.PubMed Scarsi KK, Fotis MA, Noskon GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002;59:2089–92.PubMed
5.
go back to reference Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW. Pharmacist Participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282(3):267–70.PubMedCrossRef Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW. Pharmacist Participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282(3):267–70.PubMedCrossRef
6.
7.
go back to reference Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695–700.PubMedCrossRef Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695–700.PubMedCrossRef
8.
go back to reference Needham DS, Wong IC, Campion PD. Evaluation of the effectiveness of UK community pharmacists’ interventions in community palliative care. Palliat Med. 2002;16(3):219–25.PubMedCrossRef Needham DS, Wong IC, Campion PD. Evaluation of the effectiveness of UK community pharmacists’ interventions in community palliative care. Palliat Med. 2002;16(3):219–25.PubMedCrossRef
9.
go back to reference Buurma H, De Smet PA, Leufkens HG, Egberts TCG. Evaluation of the clinical value of pharmacists’ modifications of prescription errors. Br J Clin Pharmacol. 2004;58(5):503–11.PubMedCrossRef Buurma H, De Smet PA, Leufkens HG, Egberts TCG. Evaluation of the clinical value of pharmacists’ modifications of prescription errors. Br J Clin Pharmacol. 2004;58(5):503–11.PubMedCrossRef
10.
go back to reference Buurma H, de Smet PA, van den Hoff OP, Egberts TCG. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001;52(1):85–91.PubMedCrossRef Buurma H, de Smet PA, van den Hoff OP, Egberts TCG. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001;52(1):85–91.PubMedCrossRef
11.
go back to reference Van den Bemt PMLA, Egberts ACG, Lenderink AW, Verzijl JM, Simons KA, van der Pol WSJCM, Leufkens HGM. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000;22(2):62–6.PubMedCrossRef Van den Bemt PMLA, Egberts ACG, Lenderink AW, Verzijl JM, Simons KA, van der Pol WSJCM, Leufkens HGM. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000;22(2):62–6.PubMedCrossRef
12.
go back to reference Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a USA consensus panel of experts. Arch Intern Med 2003;163:2716–24.PubMedCrossRef Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a USA consensus panel of experts. Arch Intern Med 2003;163:2716–24.PubMedCrossRef
13.
go back to reference American Society of Health System Pharmacists (ASHP) “Clinical Skills Program”, module 3–5, 1993. American Society of Health System Pharmacists (ASHP) “Clinical Skills Program”, module 3–5, 1993.
14.
go back to reference Overhage M, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm 1999; 56(23):2444–50.PubMed Overhage M, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm 1999; 56(23):2444–50.PubMed
15.
go back to reference Dutch Scientific Institute for Pharmacy Dutch manual for drug substitution, May 2004. www. WINAp.nl. Dutch Scientific Institute for Pharmacy Dutch manual for drug substitution, May 2004. www. WINAp.nl.
16.
go back to reference McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997;156:385–91. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997;156:385–91.
17.
go back to reference Van den Bemt PMLA. Costs and benefits of detecting prescribing errors. Thesis: Drug safety in hospitalised patients. Rijksuniversiteit Groningen 2002;Ch 4.2:75–88. Van den Bemt PMLA. Costs and benefits of detecting prescribing errors. Thesis: Drug safety in hospitalised patients. Rijksuniversiteit Groningen 2002;Ch 4.2:75–88.
18.
go back to reference Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997;54(14):1591–5.PubMed Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997;54(14):1591–5.PubMed
19.
go back to reference Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy 2003;23(1):113–32.PubMedCrossRef Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy 2003;23(1):113–32.PubMedCrossRef
20.
go back to reference Van Roon EN, Wu MD, Idzinga F, Van den Bemt PMLA, Jansen TLTA, Houtman PM, Van de Laar, MAFJ, Brouwers JRBJ. A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs. Thesis Groningen University 2005: Practice research in the field of rheumatoid arthritis. Van Roon EN, Wu MD, Idzinga F, Van den Bemt PMLA, Jansen TLTA, Houtman PM, Van de Laar, MAFJ, Brouwers JRBJ. A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs. Thesis Groningen University 2005: Practice research in the field of rheumatoid arthritis.
21.
go back to reference Dale A, Copeland R, Barton R. Precribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract 2003;11:19–24.CrossRef Dale A, Copeland R, Barton R. Precribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract 2003;11:19–24.CrossRef
Metadata
Title
Evaluation of pharmacist clinical interventions in a Dutch hospital setting
Authors
Liesbeth Bosma
Frank G. A. Jansman
Anton M. Franken
Johannes W. Harting
Patricia M. L. A. Van den Bemt
Publication date
01-01-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-007-9136-9

Other articles of this Issue 1/2008

International Journal of Clinical Pharmacy 1/2008 Go to the issue